Back to Search Start Over

Benchmark dose analyses of multiple genetic toxicity endpoints permit robust, cross-tissue comparisons of MutaMouse responses to orally delivered benzo[a]pyrene.

Authors :
Long, Alexandra S.
Wills, John W.
Krolak, Dorothy
Guo, Matthew
Dertinger, Stephen D.
Arlt, Volker M.
White, Paul A.
Source :
Archives of Toxicology. Feb2018, Vol. 92 Issue 2, p967-982. 16p. 6 Graphs.
Publication Year :
2018

Abstract

Genetic damage is a key event in tumorigenesis, and chemically induced genotoxic effects are a human health concern. Although genetic toxicity data have historically been interpreted using a qualitative screen-and-bin approach, there is increasing interest in quantitative analysis of genetic toxicity dose–response data. We demonstrate an emerging use of the benchmark dose (BMD)-approach for empirically ranking cross-tissue sensitivity. Using a model environmental carcinogen, we quantitatively examined responses for four genetic damage endpoints over an extended dose range, and conducted cross-tissue sensitivity rankings using BMD100 values and their 90% confidence intervals (CIs). MutaMouse specimens were orally exposed to 11 doses of benzo[a]pyrene. DNA adduct frequency and <italic>lacZ</italic> mutant frequency (MF) were measured in up to 8 tissues, and <italic>Pig</italic>-<italic>a</italic> MF and micronuclei (MN) were assessed in immature (RETs) and mature red blood cells (RBCs). The cross-tissue BMD pattern for <italic>lacZ</italic> MF is similar to that observed for DNA adducts, and is consistent with an oral route-of-exposure and differences in tissue-specific metabolism and proliferation. The <italic>lacZ</italic> MF BMDs were significantly correlated with the tissue-matched adduct BMDs, demonstrating a consistent adduct conversion rate across tissues. The BMD CIs, for both the <italic>Pig</italic>-<italic>a</italic> and the MN endpoints, overlapped for RETs and RBCs, suggesting comparable utility of both cell populations for protracted exposures. Examination of endpoint-specific response maxima illustrates the difficulty of comparing BMD values for a fixed benchmark response across endpoints. Overall, the BMD-approach permitted robust comparisons of responses across tissues/endpoints, which is valuable to our mechanistic understanding of how benzo[a]pyrene induces genetic damage. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
03405761
Volume :
92
Issue :
2
Database :
Academic Search Index
Journal :
Archives of Toxicology
Publication Type :
Academic Journal
Accession number :
128089993
Full Text :
https://doi.org/10.1007/s00204-017-2099-2